Chloe E. James

Pessac-sur-dordogne, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

The Reply.

The Reply.

Journal: The American journal of medicine

Published: May 21, 2026

Autoimmunity and peginterferon therapy for polycythemia vera.

Autoimmunity and peginterferon therapy for polycythemia vera.

Journal: HemaSphere

Published: March 27, 2026

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target.

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target.

Journal: Cell stem cell

Published: August 04, 2025

TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs.

TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs.

Journal: The American journal of medicine

Published: June 25, 2025

Identification of Hepatic-like EPO as a Cause of Polycythemia.

Identification of Hepatic-like EPO as a Cause of Polycythemia.

Journal: The New England journal of medicine

Published: April 30, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets.

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets.

Journal: Journal of visualized experiments : JoVE

Published: December 13, 2024

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies.

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies.

Journal: eLife

Published: December 12, 2024

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.

Journal: Leukemia

Published: August 13, 2024

How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms.

How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms.

Journal: Blood

Published: July 24, 2024

Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian university.

Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian university.

Journal: Research and practice in thrombosis and haemostasis

Published: April 09, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026